Longevity Bros
Home › Glossary › NR (nicotinamide riboside)
Glossary

Nicotinamide riboside (NR): the best-trialled NAD+ precursor, and what it has shown

NR is the NAD+ precursor with the most placebo-controlled trials behind it. That makes it the most honest entry in the category: the NAD+ goes up, and not much else does.

Reviewed by the Longevity Bros team · Updated 1 October 2026

Before you read onResearch and educational information for adults, not medical advice. This entry explains one longevity term — what it means, why it matters and what the evidence says — and nothing here diagnoses, treats, cures or prevents any condition. Baseline labs come before anything, and your own physician has the final word. Longevity Bros offers coaching and written research protocols only — we do not sell, supply, source or ship any compound.

What it means

Nicotinamide riboside is a form of vitamin B3 discovered in milk and converted to NAD+ via the NRK enzymes. It is sold under the Niagen trade name and in generic capsules, usually 250–1,000 mg per day. It has generally recognised-as-safe status in the US and a novel-food authorisation in the EU, which NMN does not.

Like NMN, it raises whole-blood NAD+ within days; the two are compared in detail on the NAD+ entry.

Why it matters for longevity

NR matters mostly as the test case for the NAD+ hypothesis. If raising NAD+ in people produced the metabolic and mitochondrial benefits seen in old mice, NR trials would have shown it. They have raised NAD+ reliably and shown small or no functional changes, which is informative in itself.

What the evidence says

Martens 2018 (Nature Communications): 24 adults aged 55–79, 1 g/day for six weeks, crossover. Blood NAD+ up about 60%; no significant change in blood pressure, arterial stiffness or exercise capacity. Dollerup 2018: 40 obese men, 2 g/day for twelve weeks; no change in insulin sensitivity, mitochondrial respiration or body composition. Elhassan 2019: 12 older men, 1 g/day for 21 days; raised muscle NAD+ metabolites, no change in mitochondrial function, some reduction in inflammatory cytokines.

A 2023 trial in Parkinson's disease reported mild symptom improvement on 1 g/day; a heart-failure pilot showed improved mitochondrial respiration in blood cells. Nothing on lifespan or disease prevention.

How to measure or use it

Related

Frequently asked questions

How much NR raises NAD+?

250 mg/day roughly doubles it over several weeks in some studies; 1 g/day raised it about 60% in Martens 2018. More is not clearly better.

Is NR better than NMN?

NR has more and better-controlled trials and clearer regulatory status. The functional results of the two are similar — small.

Does NR lower inflammation?

One trial (Elhassan 2019) found reduced IL-6 and IL-2 in older men. It is a single small result, not a replicated effect.

Your own protocol

Want this applied to your own numbers?

Fifteen minutes of intake, your labs, a human-reviewed protocol within about 24 hours, three documents, a free coach call and check-ins through the cycle. €399, follow-up included.

Build my protocol Book a 15-minute call